Detalles de la búsqueda
1.
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
Circulation
; 149(23): e1239-e1311, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38718139
2.
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 396(10253): 759-769, 2020 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32871100
3.
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
J Am Coll Cardiol
; 83(23): 2324-2405, 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38727647
4.
Study Design and Rationale of EXPLORER-HCM: Evaluation of Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Circ Heart Fail
; 13(6): e006853, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32498620
Resultados
1 -
4
de 4
1
Próxima >
>>